These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 8442038)

  • 1. Hypercoagulable state as a risk factor in transplantation.
    Edwards CM; Morgan JD; Donnelly PK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1051. PubMed ID: 8442038
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine therapy in pancreas transplantation.
    Davidson I; Lu C; Melone D; Risser R
    Transplant Proc; 1996 Aug; 28(4):2134-5. PubMed ID: 8769179
    [No Abstract]   [Full Text] [Related]  

  • 3. Tonsillar carcinoma in a renal graft recipient treated with cyclosporine A.
    Swoboda A; Fabrizii V
    Clin Nephrol; 1993 May; 39(5):272-4. PubMed ID: 8513605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To keep a stable therapeutic level of cyclosporine during the early posttransplant period is important in graft survival.
    Ahn MS; Ha J; Yun IJ; Kim S; Lee JS; Kim S; Han JS; Ahn C; Choi Y; Cheong HI; Kim ST; Kim SJ
    Transplant Proc; 1996 Jun; 28(3):1316-7. PubMed ID: 8658675
    [No Abstract]   [Full Text] [Related]  

  • 5. [Magnesium deficiency after kidney transplantation and cyclosporine therapy].
    Rob PM
    Fortschr Med; 1996 Apr; 114(10):125-6. PubMed ID: 8655118
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine-associated thrombotic microangiopathy: report of two cases with good outcome and successful subsequent reuse.
    Dhib M; Moulin B; Abderrahim E; Etienne I; Godin M; Fillastre JP
    Transplant Proc; 1993 Jun; 25(3):2294-6. PubMed ID: 8516905
    [No Abstract]   [Full Text] [Related]  

  • 7. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical study of sandimmun neoral in cadaveric renal transplantation.
    Xue W; Chen Y; Xing J; Tian P
    Transplant Proc; 1996 Jun; 28(3):1333-4. PubMed ID: 8658682
    [No Abstract]   [Full Text] [Related]  

  • 9. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
    Schulz T; Kapischke M; Busing M
    Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aseptic thrombosis of the intracranial venous sinuses in a patient with kidney transplantation and toxic levels of cyclosporine].
    Guerrero AL; Arcaya J; Cacho J; Seisdedos L
    Med Clin (Barc); 1999 Feb; 112(6):238-9. PubMed ID: 10191492
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumors after transplantation: are there associated factors?
    Jacobs U; Paar D; Buszello H; Klehr HU
    Transplant Proc; 1996 Dec; 28(6):3248. PubMed ID: 8962258
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospective randomized study of triple vs conventional immunosuppression in living donor kidney transplantation.
    Ghoneim MA; Sobh MA; Shokeir AA; Bakr MA; el-Sherif A; Foda MA
    Transplant Proc; 1993 Jun; 25(3):2243-5. PubMed ID: 8516887
    [No Abstract]   [Full Text] [Related]  

  • 13. Hypercoagulable state associated with kidney-pancreas transplantation. Thromboelastogram-directed anti-coagulation and implications for future therapy.
    Burke GW; Ciancio G; Figueiro J; Buigas R; Olson L; Roth D; Kupin W; Miller J
    Clin Transplant; 2004 Aug; 18(4):423-8. PubMed ID: 15233820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporine nephrotoxicity: associated allograft dysfunction at low trough concentration.
    Jankauskiene A; Druskis V; Laurinavicius A
    Clin Nephrol; 2001 Dec; 56(6):S27-9. PubMed ID: 11770808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors and early resumption of cyclosporin A in renal allograft recipients with thrombotic microangiopathy and hemolytic uremic syndrome.
    Wiener Y; Nakhleh RE; Lee MW; Escobar FS; Venkat KK; Kupin WL; Mozes MF
    Clin Transplant; 1997 Jun; 11(3):157-62. PubMed ID: 9193835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of kidney functions and cyclosporine levels in renal transplant patients on Panimum Bioral in post transplant period.
    Sharma DR; Singh S
    J Indian Med Assoc; 1999 May; 97(5):204-5. PubMed ID: 10652891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
    Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
    Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
    [No Abstract]   [Full Text] [Related]  

  • 18. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B; Vester U; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posttransplant diabetes mellitus in cyclosporine-treated renal allograft patients: a case-control study.
    Copstein LA; Zelmanovitz T; Gonçalves LF; Manfro RC
    Transplant Proc; 2004 May; 36(4):882-3. PubMed ID: 15194302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged renal allograft survival in chronic rejection by conversion to triple therapy.
    Beckingham IJ; Dennis MJ; Innes A; Burden RP; Morgan AG; Bishop MC
    Transplant Proc; 1993 Apr; 25(2):2100. PubMed ID: 8470283
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.